Lineage Cell Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Lineage Cell Therapeutics, Inc. (LCTX) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.25 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-05-09
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.25M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.25M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $918.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.05M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-03-31 | $1.25M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.25M 10-K · filed 2019-03-14 |
| 2017-12-31 | $918.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $1.05M 10-K · filed 2017-03-16 |
| 2015-12-31 | $2.22M 10-K · filed 2016-03-15 |
| 2014-12-31 | $1.35M 10-K · filed 2015-03-11 |
| 2013-12-31 | $1.27M 10-K · filed 2014-03-17 |
| 2012-12-31 | $32.63K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |